Literature DB >> 21812355

Teleradiology: friend or foe? What imaging's now indispensable partner means for radiology's future and for the quality of care.

PollyBeth Hawk1.   

Abstract

Over the past half decade, teleradiology companies have served as invaluable business partners to local radiology providers grappling with declining reimbursements, shrinking budgets, and an imaging utilization explosion that has rendered workloads unmanageable. The teleradiology business model has helped to stabilize local imaging groups through economies of scale to control costs, by facilitating rapid workflow and report turnaround times, and offering a broad range of subspecialty expertise. Teleradiology has landed radiology at an important crossroads and market forces are actively shaping its future. This article examines the role of technological innovation in teleradiology's success, and suggests that persistent technological and operational limitations raise important questions regarding quality of care. This article also joins the imaging industry's discussion as to whether radiology can be (or has been) commoditized, and explores the feasibility of the commoditization of imaging and its impact on traditional radiology practice. There appears to be an important role for teleradiology in the provision of radiology services going forward, and yet boundaries must be thoughtfully drawn in order to achieve best practices for the specialty's future. tion, commoditization.

Mesh:

Year:  2011        PMID: 21812355

Source DB:  PubMed          Journal:  J Health Care Finance        ISSN: 1078-6767


  2 in total

1.  Experiences from Decentralised Radiological Services in Norway - a rural case study.

Authors:  Aud Mette Myklebust; Hilde Eide; Brian Ellis; Rona Beattie
Journal:  BMC Health Serv Res       Date:  2019-12-12       Impact factor: 2.655

2.  Obstacles and Solutions Driving the Development of a National Teleradiology Network.

Authors:  Leonie Goelz; Holger Arndt; Jens Hausmann; Christian Madeja; Sven Mutze
Journal:  Healthcare (Basel)       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.